Study Looking at a Treatment for Acute Myeloid Leukemia (AML)

What we are studying

The study aims to look at Mylotarg as a treatment for Acute Myeloid Leukemia (AML) in individuals who have failed other options.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Acute myeloid leukemia (AML) with relapsed or refractory disease

What is involved

  • Depending on your individual circumstances you may receive one of three possible treatment regimens with Mylotarg.

Compensation

None

Contact Information

Study Coordinator
Amy Neal, RN
Email
aneal@wakehealth.edu
Phone
336-713-6912

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.